Harvard Bioscience to showcase solutions for preclinical, organoid applications
PremiumThe FlyHarvard Bioscience to showcase solutions for preclinical, organoid applications
2M ago
Harvard Bioscience sees FY24 revenue $97M-$102M
Premium
The Fly
Harvard Bioscience sees FY24 revenue $97M-$102M
3M ago
Harvard Bioscience reports Q2 adjusted EPS 0c vs. 4c last year
Premium
The Fly
Harvard Bioscience reports Q2 adjusted EPS 0c vs. 4c last year
3M ago
Harvard Bioscience announces labor force reduction to improve cost structure
PremiumThe FlyHarvard Bioscience announces labor force reduction to improve cost structure
7M ago
Harvard Bioscience Sets Incentive Plan for Top Executives
Premium
Company Announcements
Harvard Bioscience Sets Incentive Plan for Top Executives
8M ago
Harvard Bioscience sees 2024 revenue growth flat to modest, consensus $122.39M
Premium
The Fly
Harvard Bioscience sees 2024 revenue growth flat to modest, consensus $122.39M
8M ago
Harvard Bioscience management to meet with KeyBanc
PremiumThe FlyHarvard Bioscience management to meet with KeyBanc
11M ago
Harvard Bioscience sees 2023 revenue flat compared to 2022, consensus $117.31M
Premium
The Fly
Harvard Bioscience sees 2023 revenue flat compared to 2022, consensus $117.31M
1y ago
Harvard Bioscience reports Q3 adjusted EPS 1c, consensus 4c
Premium
The Fly
Harvard Bioscience reports Q3 adjusted EPS 1c, consensus 4c
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100